Envisage report cover

Patient Registry Software Market: COVID-19 Impact and Global Analysis Forecast to 2028

Published Date: May 2021

No. of Pages: 208

Status: Upcoming

Report Code: EMR100261

Patient registry databases are utilized to create clinical research in the field of uncommon and chronic diseases for the improvement of patient care. These databases are vital to survey the achievability of clinical trials and bolster patient enrolment systems to assess the effect of new innovations. In healthcare associations, for example, hospitals and nursing homes, patient registry databases gather and store patient data to characterize specific sicknesses or therapeutic conditions. Patient registries are the modernized databases that hold individual, restorative, social, and cash related information being accounted for by medicinal services specialists and patients. For rare or ceaseless diseases, registries can give crucial epidemiological information, such as, frequency and common, side effects, and seriousness of the infection to scientists and social insurance specialists. As the ceaseless development of endless ailments, populace and malady administration is exceedingly required, which thus drives the general interest for patient registry software. The developing interest for patient registry software has prompted the rise of patient registry software providers around the globe, which has added to the development of market comprehensively.

In terms of geography, North America rules the global market in patient registry. This is because of the presence of an enhanced social healthcare infrastructure and expanded government funding for the medical sector in the region. Moreover, innovative progression in persistent registry software stages and in addition expanding appropriation of electronic healthcare records (EHRs) in medicinal practices have likewise impelled the development of the market in North America. Moreover, expanding weights of government on social insurance associations to enhance the nature of care and limit medicinal services cost have likewise pushed the development of the patient registry software market in the province. India, China, and Japan are anticipated to be the quickest developing markets for patient registry software in Asia Pacific. Different activities attempted by government associations to improve tolerant healthcare administration and expanding pervasiveness of chronic diseases are among the real drivers for the global patient registry software market. Additionally, expanding appropriation of EHRs and expanding government spending on human services associations to enhance patient care have boosted the development of this market. Absence of medicinal services IT experts and information protection and security worries in EHRs are significant restrictions of the global patient registry software market. Expanding number of mergers and acquisitions between social insurance IT organizations is a key trend witnessed in the global patient registry software market.

The global patient registry market can be segmented on the basis of database type, product type, deployment model, functionality, pricing model, end-user and geography. Based on database type the global patient registry software market can be segmented into product registries and health service registries. Based on deployment model, the global patient registry software market can be segmented into integrated software and standalone software. Based on product type, the global patient registry software market can be divided into on-premise models and cloud-based model. Based on pricing model, the global patient registry software market can be segmented into on subscription models and ownership models. On the basis of functionality, the global patient registry software market can be segmented into health information exchange (HIE), medical research, population health management (PHM), point of care, patient care management, product outcome evaluation and clinical studies. Based on end-user, the global patient registry software market can be segmented into government organizations and third-party administrators (tpas), pharmaceutical, hospitals, biotechnology, private payers and medical device companies and research centers. On the basis of geography, the global patient registry market can be segmented into Asia-Pacific, Europe, North America and Rest of the World.

Some of the key players in the global patient registry software market include Patient Crossroads, Quintiles, Inc., Dacima Software, Inc., Evado Clinical Solution, Global Vision Technologies, Inc., Global Vision Technologies, Inc., ImageTrend, Inc., Velos, Inc., IFA systems AG, Optum, Inc. and Telligen, Inc. among others.

The global patient registry market can be segmented

By Database Type:
• Product registries
• Health service registries

By Product Type:
• On-premise models
• Cloud-based model

By Deployment Model:
• Integrated software
• Standalone software

By Functionality:
• Health information exchange (HIE)
• Medical research
• Population health management (PHM)
• Point of care
• Patient care management
• Product outcome evaluation
• Clinical studies

By Pricing Model:
• On subscription models
• Ownership models

By End-User:
• Government organizations and third-party administrators (tpas)
• Pharmaceutical
• Hospitals
• Biotechnology
• Private payers
• Medical device companies
• Research centres

By Region:
• Asia-Pacific
• Europe
• North America
• Rest of the World  

The Leading Key Players in Patient Registry Software Market

Patient Crossroads
Quintiles Inc.
Dacima Software Inc.
Evado Clinical Solution
Global Vision Technologies Inc.
Global Vision Technologies Inc.
ImageTrend Inc.
Velos Inc.
IFA systems AG
Optum Inc.
Telligen Inc.